Association between the SLC6A12 gene and negative symptoms of schizophrenia in a Korean population

Psychiatry Research

Volumn 189, Issue 3, 2011, Pages 478-479

  Park, Hae Jeong ^a   Kim, Jong Woo ^a   Lee, Seo Kyung ^a   Kim, Su Kang ^a   Park, Jin Kyung ^a   Cho, Ah Rang ^a   Chung, Joo Ho ^a   Song, Ji Young ^a  

^a Kyung Hee University Hospital   (South Korea)

Author keywords

Schizophrenia; Single nucleotide polymorphism; Solute carrier family 6

Indexed keywords

4 AMINOBUTYRIC ACID CARRIER; ALANINE; ARGININE; CYSTEINE; SERINE; SOLUTE CARRIER FAMILY 6 MEMBER 11; SOLUTE CARRIER FAMILY 6 MEMBER 12; SOLUTE CARRIER FAMILY 6 MEMBER 13; THREONINE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; ETHNICITY; EXON; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HAPLOTYPE; HUMAN; KOREAN; MAJOR CLINICAL STUDY; MALE; NEGATIVE SYNDROME; PRIORITY JOURNAL; SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS SCARE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOMATOLOGY;

ADULT; CARRIER PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; REPUBLIC OF KOREA; SCHIZOPHRENIA;

EID: 80053439621     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.01.023     Document Type: Article

References (13)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Press, Washington, DC.
2. Andreasen N.C. Negative symptoms in schizophrenia. Definition and reliability. Archives of General Psychiatry 1982, 39:784-788.
3. Borden L.A. GABA transporter heterogeneity: pharmacology and cellular localization. Neurochemistry International 1996, 29:335-356.
4. Bullock W.M., Cardon K., Bustillo J., Roberts R.C., Perrone-Bizzozero N.I. Altered expression of genes involved in GABAergic transmission and neuromodulation of granule cell activity in the cerebellum of schizophrenia patients. American Journal of Psychiatry 2008, 165:1594-1603.
5. Fanous A.H., van den Oord E.J., Riley B.P., Aggen S.H., Neale M.C., O'Neill F.A., Walsh D., Kendler K.S. Relationship between a high-risk haplotype in the DTNBP1 (dysbindin) gene and clinical features of schizophrenia. American Journal of Psychiatry 2005, 162:1824-1832.
6. Komar A.A. Silent SNPs: impact on gene function and phenotype. Pharmacogenomics 2007, 8:1075-1080.
7. McGuffin P., Farmer A., Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Archives of General Psychiatry 1991, 48:764-770.
8. Perry T.L., Buchanan J., Kish S.J., Hansen S. Gamma-aminobutyric acid deficiency in brains of schizophrenic patients. Lancet 1979, 1:237-239.
9. Pierri J.N., Chaudry A.S., Woo T.U., Lewis D.A. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. American Journal of Psychiatry 1999, 156:1709-1719.
10. Schleimer S.B., Hinton T., Dixon G., Johnston G.A. GABA transporters GAT-1 and GAT-3 in the human dorsolateral prefrontal cortex in schizophrenia. Neuropsychobiology 2004, 50:226-230.
11. Ying S.Y., Chang C.P., Lin S.L. Intron-mediated RNA interference, intronic microRNAs, and applications. Methods in molecular biology 2010, 629:205-237.
12. Zai C.C., Tiwari A.K., King N., DeLuca V., Mueller D.J., Shaikh S., Wong G.W., Meltzer H.Y., Lieberman J.A., Kennedy J.L. Association study of the gamma-aminobutyric acid type a receptor gamma2 subunit gene with schizophrenia. Schizophrenia Research 2009, 114:33-38.
13. Zhao X., Qin S., Shi Y., Zhang A., Zhang J., Bian L., Wan C., Feng G., Gu N., Zhang G., He G., He L. Systematic study of association of four GABAergic genes: glutamic acid decarboxylase 1 gene, glutamic acid decarboxylase 2 gene, GABA(B) receptor 1 gene and GABA(A) receptor subunit beta2 gene, with schizophrenia using a universal DNA microarray. Schizophrenia Research 2007, 93:374-384.